Biosimilars Patent Challenges at the PTAB

This webinar will cover biosimilar patent challenges at the PTAB. We will explore topics including:

• The type of biologics patents being challenged at the PTAB and the success rate for each type
• Timing of challenges relative to aBLA filing/litigation
• Number of challenges for given patent/given drug
• Implications of results of these PTAB challenges for biologics manufacturers
• Strategies for biosimilars companies in light of PTAB stats

Visit this page to register.